Upstream Fertility Health.
Most women trying to conceive aren't going to a fertility clinic. And they want to be pregnant yesterday.
Most women trying to conceive aren't going to a fertility clinic. And they want to be pregnant yesterday.
Women spend years preventing pregnancy with no roadmap for when they're ready to conceive. Then a fertility clinic runs $20,000 per IVF cycle. FertiHealth closes that gap upstream: before the clinic, before the diagnosis, before the crisis. It keeps working alongside treatment once that has begun.
Every interaction is anchored in evidence-based clinical guidelines.
Sources: WHO · Milman et al., Fertility & Sterility (2017) · Grand View Research & IBISWorld (U.S. fertility, 2024) · ASRM Ethics Committee, Disparities in Access to Effective Treatment for Infertility (2021).
Her cycle app picked a day and sounded certain about it. It's right about a quarter of the time. The Reddit thread at 1 a.m. is worse. What she gets from us is an answer from doctors who treat infertility every day, grounded in peer-reviewed guidance from ASRM, SART, ACOG, and ACLM — and one thing to change this week.
Four products, plus a path into real care: education, analysis, and coaching. A woman might use one or all four, on recurring subscriptions at a personalized cadence — one we recommend from her answers and her motivation to change. Every one feeds the same dataset, and the insights it will make possible.
The clinic opens its door after 12 months of trying. We start at −3.
FertiHealth's products generate what doesn't exist today: a prospective, longitudinal dataset linking behaviors, biomarker trajectories, and reproductive outcomes.
Fertility apps track cycles. Wearables track biomarkers. Lab subscriptions return results without telling her what to change. Clinics run diagnostics after a 12-month delay. None of them connect guidance, coaching, and biomarker assessment into one pipeline. None have operationalized STRAW+10, the gold-standard framework for reproductive aging, at commercial scale.
Every cycle is an opportunity to intervene. We focus on health, not on pregnancy — and we never ask her whether this was the month, which would only add anxiety. When it happens, she tells us, with months of behavior and biomarkers already behind it.
As it grows, the dataset predicts fertility decline before it becomes infertility. ARPA-H has called for exactly that. Our architecture is built for it.
Fertility is where she arrives. Hormonal and metabolic health is what she stays for. The biomarkers that tell her how soon to act are the same ones that map the perimenopausal transition a decade later. Most fertility companies lose the user the moment she succeeds.
Every product feeds one dataset. Every user makes it more valuable. That compounding is the company's core asset.
Women are drowning in health information, but legitimate care from a doctor is hard to come by. The gaps are growing. Women wait months to get a diagnosis and treatment for infertility, PCOS, endometriosis, recurrent loss, or perimenopause. I built FertiHealth to change that: a fertility companion, innovative education, and AI coaching, to shorten time to pregnancy from anywhere.
I sit at the intersection of reproductive science, hormonal health, and how people actually change. I co-authored Getting to Baby to reach the women who couldn't get to my office. FertiHealth is what comes next: the same evidence base, scaled beyond the exam room.
Women's health is a continuum. Let's talk about it that way.
Investment, partnerships, press, and speaking engagements.